YBX1 and hepatocellular carcinoma: In HCC, circRNA‐SORE is essential for the maintenance of sorafenib resistance by interacting with the oncogenic protein YBX1 in the cytoplasm, preventing the nuclear translocation of YBX1 and subsequently blocking PRP19‐mediated YBX1 ubiquitination and proteasomal degradation in the nucleus.55